Israeli hospital to start fourth Covid jab efficacy study

Sheba Medical Center will administer a fourth dose to 150 medical workers who were vaccinated with third doses before August 20.
Image: Hannah Beier/Bloomberg

A leading Israeli hospital has started what it says is the first formal clinical trial examining the safety and efficacy of a fourth dose of coronavirus vaccine.

Sheba Medical Center has begun to administer a fourth dose to 150 medical workers who received third doses before August 20 and currently have a low antibody count, according to a statement from the hospital. The trial is being done in conjunction with Israel’s Health Ministry.

Prime Minister Naftali Bennett announced last week that the government would adopt the recommendation of a panel of experts to inoculate older adults and medical personnel with a fourth dose of Pfizer-BioNTech vaccine in a bid to shore up protection against the fast-spreading omicron variant.

However, a few days later, the Health Ministry said its director-general had not yet decided whether to go ahead with the immunisation drive. Some experts had questioned the wisdom of a fourth shot given the paucity of supporting data.

Initial data regarding safety will be available in a few days, said Professor Gili Regev-Yochay, who is spearheading the trial at Sheba.

© 2021 Bloomberg L.P.

COMMENTS   0

You must be signed in and an Insider Gold subscriber to comment.

SUBSCRIBE NOW SIGN IN

LATEST CURRENCIES  

USD / ZAR
GBP / ZAR
EUR / ZAR
BTC / USD
INSIDER SUBSCRIPTION APP VIDEOS RADIO / LISTEN LIVE SHOP OFFERS WEBINARS NEWSLETTERS TRENDING

Follow us: